Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

22. Oct 2019 | 2 min read

Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

 

Podcast: CEO Dr Hilja Ibert at BioTalk

Gentian’s CEO Dr Hilja Ibert, PhD, joined BioTalk host Rich Bendis, Founder, President and CEO BioHealth Innovation Inc. at the Capital Region Investor Conference last week. In this podcast Dr Ibert talks about Gentian’s presence in the US market, biomarkers and how Gentian focuses on innovating diagnostic efficiency.

Listen to the podcast now:

 

 

HiljaandRichRecording_web-ready

 

BioHealth Innovation and Gentian

Gentian’s subsidiary in the US, Gentian USA, Inc. collaborates with BioHealth Innovation (BHI) in order to expand Gentian’s presence in the USA. BHI is an innovation intermediary that translates relevant market research into commercial success by connecting management, funding, and markets. The collaboration allows Gentian to support current and new US customers and OEM partners more closely, and will also make Gentian's products more visible to a larger US customer base.

 

You may also read


Webinar: Calprotectin in sepsis

Sep 14, 2020

Webinar: Calprotectin in sepsis

In relation to World Sepsis Day  and Sepsis Awareness Month we have decided to make a webinar on the..

World Sepsis Day 2020: Calprotectin in sepsis

Sep 11, 2020

World Sepsis Day 2020: Calprotectin in sepsis

#WorldSepsisDay September is Sepsis awareness month, and the 9th World Sepsis Day, an initiative by..

Webinar: The clinical value of cystatin C, by Dr. E. Sundrehagen, CSO

Sep 08, 2020

Webinar: The clinical value of cystatin C, by Dr. E. Sundrehagen, CSO

Cystatin C is a superior glomerular filtration rate (GFR) marker for the diagnosis and therapeutic control of..